maximally tolerated doses การใช้

• In a clinical study that compared the efficacy and safety of using Levemir for the treatment of patients with type 2 diabetes who had suboptimal glycemic control while receiving maximally tolerated doses of metformin and sulfonylurea ( common tablet therapies for type 2 diabetes ), it was found that, " At 24 weeks, HbA 1c ( glycosylated hemoglobin ) had decreased by 1.8 and 1.9 % ( from 8.6 to 6.8 and from 8.5 to 6.6 % ) for detemir and NPH, respectively ( NS ).